论文部分内容阅读
目的:探讨阿托品联合奥美拉唑治疗急性胃炎的临床疗效。方法:选取2015年11月-2016年11月我院收治的急性胃炎患者120例作为研究对象,按照随机平均原则分为对照组和实验组。其中对照组采用山莨菪碱联合奥美拉唑治疗,实验组采用阿托品联合奥美拉唑治疗。将两组患者的临床疗效与不良反应进行记录和分析。结果:实验组患者的临床治疗效果93.33%(56/60)明显优于对照组70%(42/60),P<0.05,差异有统计学意义。对照组的不良反应率为10%,实验组不良反应率为8.33%,组间比较差异无统计学意义,P>0.05。结论:采用阿托品联合奥美拉唑治疗急性胃炎可有效缓解患者的疼痛症状,在临床治疗中安全性较高,治疗效果显著,值得在临床上进一步推广使用。
Objective: To investigate the clinical efficacy of atropine and omeprazole in the treatment of acute gastritis. Methods: A total of 120 acute gastritis patients admitted in our hospital from November 2015 to November 2016 were selected as the research subjects, and divided into control group and experimental group according to the principle of randomization. The control group was treated with anisodamine and omeprazole, and the experimental group was treated with atropine and omeprazole. The clinical efficacy and adverse reactions of two groups of patients were recorded and analyzed. Results: The clinical efficacy of the experimental group was 93.33% (56/60), which was significantly better than that of the control group (70%, 42/60), P <0.05. The difference was statistically significant. The rate of adverse reactions in the control group was 10%, and the rate of adverse reactions in the experimental group was 8.33%. There was no significant difference between the two groups (P> 0.05). Conclusion: The combination of atropine and omeprazole in the treatment of acute gastritis can effectively relieve the pain symptoms of patients. It is safe in clinical treatment and has significant therapeutic effect. It is worth further promotion in clinic.